Precision medicine for prostate cancer—improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier

Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer. JAMA. 2017;317:2532.

Article  PubMed  Google Scholar 

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65:1046–55.

Article  PubMed  PubMed Central  Google Scholar 

Ebrahimizadeh W, Guérard KP, Rouzbeh S, Bramhecha YM, Scarlata E, Brimo F, et al. Design and development of a fully synthetic multiplex ligation-dependent probe amplification–based probe mix for detection of copy number alterations in prostate cancer formalin-fixed, paraffin-embedded tissue samples. J Mol Diagn. 2020;22:1246–63.

Article  CAS  PubMed  Google Scholar 

Liu W, Hou J, Petkewicz J, Na R, Wang C, Sun J, et al. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression. Prostate. 2020;80:1253–62.

Article  CAS  PubMed  Google Scholar 

Fu X, Shi Y, Ma J, Zhang K, Wang G, Li G, et al. Advances of multiplex ligation-dependent probe amplification technology in molecular diagnostics. Biotechniques. 2022;73:205–13.

Article  CAS  Google Scholar 

Ebrahimizadeh W, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Patel PG, et al. A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. Br J Cancer. 2023;128.

Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015;2:1133–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Espiritu SMG, Liu LY, Rubanova Y, Bhandari V, Holgersen EM, Szyca LM, et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell. 2018;173:1003–13.e15.

Article  CAS  PubMed  Google Scholar 

Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncol. 2014;15:1521–32.

Article  PubMed  Google Scholar 

Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33:272–7.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif